Tryptophan hydroxylase and catechol-O-methyltransferase gene polymorphisms: relationships to monoamine metabolite concentrations in CSF of healthy volunteers

被引:101
作者
Jonsson, EG [1 ]
Goldman, D
Spurlock, G
Gustavsson, JF
Nielsen, DA
Linnoila, M
Owen, MJ
Sedvall, GC
机构
[1] Karolinska Inst, Psychiat Sect, Dept Clin Neurosci, SE-17176 Stockholm, Sweden
[2] NIAAA, Neurogenet Lab, Div Intramural Clin & Biol Res, Rockville, MD 20892 USA
[3] Univ Wales Coll Med, Inst Med Genet, Cardiff CF4 4XN, S Glam, Wales
[4] NIAAA, Clin Studies Lab, Div Intramural Clin & Biol Res, Bethesda, MD 20892 USA
关键词
tryptophan hydroxylase gene; catechol-O-methyltransferase gene; monoamine;
D O I
10.1007/BF02922258
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Concentrations of monoamine metabolites (MM) in lumbar cerebrospinal fluid (CSF) have been used extensively as indirect estimates of monoamine turnover in the brain. We investigated possible relationships between DNA polymorphisms in the tryptophan hydroxylase (TPH) and catechol-O-methyltransferase (COMT) genes and CSF concentrations of 5-hydroxyindoleacetic acid (5-HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxyphenylglycol (MHPG) in healthy volunteers (n = = 66). Lower CSF 5-HIAA levels were found in men with the TPH U allele (p = 0.005), but not in women. A similar but less significant pattern was observed for CSF HVA. No relationship was found between the TPH polymorphism and CSF MHPG. COMT genotypes did not relate significantly to MM concentrations. The results suggest that TPH genotypes participate differentially in the regulation of serotonin turnover rate under presumed steady state in the central nervous system of men. Due to the uncertain functional relevance of the DNA polymorphism investigated and the many calculations performed, the results should be interpreted with caution until replicated.
引用
收藏
页码:297 / 302
页数:6
相关论文
共 35 条
[1]  
ABBAR M, 1995, ARCH GEN PSYCHIAT, V52, P846
[2]   INTERACTING NEUROTRANSMITTER SYSTEMS - A NONEXPERIMENTAL APPROACH TO THE 5HIAA-HVA CORRELATION IN HUMAN CSF [J].
AGREN, H ;
MEFFORD, IN ;
RUDORFER, MV ;
LINNOILA, M ;
POTTER, WZ .
JOURNAL OF PSYCHIATRIC RESEARCH, 1986, 20 (03) :175-193
[3]  
[Anonymous], 1987, DIAGNOSTIC STAT MANU, V4th
[4]  
AXELROD J, 1958, J BIOL CHEM, V233, P702
[5]   HUMAN LIVER CATECHOL-O-METHYLTRANSFERASE PHARMACOGENETICS [J].
BOUDIKOVA, B ;
SZUMLANSKI, C ;
MAIDAK, B ;
WEINSHILBOUM, R .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (04) :381-389
[6]  
BRAHE C, 1986, HUM GENET, V74, P230
[7]  
COOPER JR, 1961, J PHARMACOL EXP THER, V132, P265
[8]   LOCALIZATION OF HUMAN TRYPTOPHAN-HYDROXYLASE (TPH) TO CHROMOSOME-11P15.3-]P14 BY INSITU HYBRIDIZATION [J].
CRAIG, SP ;
BOULARAND, S ;
DARMON, MC ;
MALLET, J ;
CRAIG, IW .
CYTOGENETICS AND CELL GENETICS, 1991, 56 (3-4) :157-159
[9]  
Daniels JK, 1996, AM J PSYCHIAT, V153, P268
[10]   DIFFERENTIAL CONTROL OF TRYPTOPHAN-HYDROXYLASE EXPRESSION IN RAPHE AND IN PINEAL-GLAND - EVIDENCE FOR A ROLE OF TRANSLATION EFFICIENCY [J].
DUMAS, S ;
DARMON, MC ;
DELORT, J ;
MALLET, J .
JOURNAL OF NEUROSCIENCE RESEARCH, 1989, 24 (04) :537-547